Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Salt Lake City, Utah 84106


Purpose:

This study is the first human exposure for the drug candidate CTS21166 in healthy male volunteers


Criteria:

Inclusion Criteria: - Healthy adult male > age 21; - non-smoker (minimum 6 months); Exclusion Criteria: - History or evidence of clinically significant cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic,neurologic, psychiatric, oncologic, or allergic (including anaphylactic drug allergies, but excluding untreated, asymptomatic, seasonal allergies at time of dosing) disease - History or evidence of intravenous illicit drug use, human immunodeficiency virus (HIV), hepatitis B, or hepatitis C; - Participation in another clinical trial within 30 days prior to dosing


NCT ID:

NCT00621010


Primary Contact:

Study Director
Henry Hsu, M.D.
CoMentis


Backup Contact:

N/A


Location Contact:

Salt Lake City, Utah 84106
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.